199 related articles for article (PubMed ID: 22654429)
1. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Choi HS; Chun HJ; Park SH; Keum B; Seo YS; Kim YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS
World J Gastroenterol; 2012 May; 18(19):2377-82. PubMed ID: 22654429
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
[TBL] [Abstract][Full Text] [Related]
3. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
[TBL] [Abstract][Full Text] [Related]
4. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.
Nasa M; Choksey A; Phadke A; Sawant P
Indian J Gastroenterol; 2013 Nov; 32(6):392-6. PubMed ID: 24158898
[TBL] [Abstract][Full Text] [Related]
5. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
[TBL] [Abstract][Full Text] [Related]
6. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
7. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
8. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
Valooran GJ; Kate V; Jagdish S; Basu D
Scand J Gastroenterol; 2011 Sep; 46(9):1045-50. PubMed ID: 21627398
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
10. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
11. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
12. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
De Francesco V; Zullo A; Margiotta M; Marangi S; Burattini O; Berloco P; Russo F; Barone M; Di Leo A; Minenna MF; Stoppino V; Morini S; Panella C; Francavilla A; Ierardi E
Aliment Pharmacol Ther; 2004 Feb; 19(4):407-14. PubMed ID: 14871280
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.
Scaccianoce G; Hassan C; Panarese A; Piglionica D; Morini S; Zullo A
Can J Gastroenterol; 2006 Feb; 20(2):113-7. PubMed ID: 16482238
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Boixeda de Miquel D
Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
[No Abstract] [Full Text] [Related]
15. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
[TBL] [Abstract][Full Text] [Related]
16. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
17. [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Gisbert JP; Mur M; Boixeda D; Ceña G; Martín de Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
Med Clin (Barc); 1997 Apr; 108(14):524-9. PubMed ID: 9190436
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
Lee SB; Park SJ; Ryu JK; Lee JK; Kim HJ; Bae JS; Jung HS; Park SM
Korean J Gastroenterol; 2003 Dec; 42(6):468-75. PubMed ID: 14695703
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
[TBL] [Abstract][Full Text] [Related]
20. Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
Romero-Gómez M; Martínez-Delgado C; Hergueta P; Navarro JM; Garrido-Serrano A; Santos O; Montojo C
Aliment Pharmacol Ther; 2003 Nov; 18(10):1023-9. PubMed ID: 14616169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]